Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us

  • Get The Newsletter!
  • View The Latest Newsletter
  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory
  • Resource Centers
    • EU MDR and IVDR Resource Center
    • Medical Device Labeling Resource Center
    • Medical Device Audits, Certification & Verification
    • Medical Device Component
    • Medical Recall Resource Center
    • Quality & Regulatory Market Access Solutions Resource Center
  • Events & Webinars
  • Library


Andrew Cleeland
February 1, 2023
Andrew Cleeland

Cleeland Joins Francis Medical Board of Directors

By MedTech Intelligence Staff
No Comments

“Francis Medical has a powerfully simple and differentiated technology, supported by an outstanding team. I’m excited to add my knowledge and experience to the group and make a meaningful impact as we strive to bring this transformational technology to urologists and their patients.”

Continue reading →

January 4, 2023

Liver-Chip Successfully Identifies Drug Toxicity, Outperforms Animal and 3D Models

By MedTech Intelligence Staff
No Comments

“The Liver-Chip detected nearly 7 out of every 8 drugs that proved hepatoxic in clinical use despite having been deemed to have an appropriate therapeutic window by animal models.”

Continue reading →

Costas Tsougarakis
December 20, 2022
Costas Tsougarakis

Laying the Groundwork for an AI Breakthrough

By Costas Tsougarakis
No Comments

Digital transformation requires a clear vision, buy-in at every level, and significant investment. Here are three steps to streamline the process.

Continue reading →

Daniel Lace
December 6, 2022
Daniel Lace

Lace To Helm New RQM+ Reimbursement Division

By MedTech Intelligence Staff
No Comments

“We are honored to have Dr. Lace, who is widely recognized as one of the industry’s most trusted reimbursement experts, leading our new division. He will also support all our services as our CMO.”

Continue reading →

WHO logo
November 27, 2022
WHO logo

WHO Convenes Panel to Identify Priority Pathogens for Research and Oversight 

By MedTech Intelligence Staff
No Comments

More than 300 scientists will consider the evidence on over 25 virus families and bacteria—as well as “Disease X” (an unknown pathogen that could cause a serious international epidemic)—and recommend a list of priority pathogens that need further research and investment.

Continue reading →

Simon Johns
November 8, 2022
Simon Johns
Soapbox

Pharma Needs a New Class of CRM Solutions

By Simon Johns
No Comments

Companies must have the right data infrastructure in place to help them determine what their customers want, when they want it and how they want to receive it. One of the most critical elements of this success is connected intelligence, which provides a full view of customer needs and expectations to everyone in the organization.

Continue reading →

J&J Abiomed Logos
November 1, 2022
J&J Abiomed Logos

Johnson & Johnson to Expand Cardiovascular Segment with Abiomed Acquisition

By MedTech Intelligence Staff
No Comments

The $16.6 billion acquisition will bring Abiomed’s breakthough Impella heart pumps into the Johnson & Johnson MedTech portfolio.

Continue reading →

Team work lightbulb
October 12, 2022
Team work lightbulb

CDRH Launches Pilot Program To Reduce Device Approval Times

By MedTech Intelligence Staff
No Comments

The goal of the TAP Pilot is to reduce the time from concept to commercialization of medical devices by facilitating robust engagement early in the process with the FDA, industry and key stakeholders.

Continue reading →

MedExecWomen Panel on M&A
September 20, 2022
MedExecWomen Panel on M&A

M&As: Maximizing the Partnership Process on Both Sides

By Leslie Storms, Kristine Ilaria, Martha Shadan
No Comments

Leslie Storms, U.S. president of Ethicon, Martha Shadan, chairwoman of Brilliant Springs Therapeutics, and Kristine Ilaria, vice president of Corporate Development at Smith+Nephew, share lessons learned from their panel “Making Acquisition Strategy Succeed: Perspectives from Both Sides of The Deal.”

Continue reading →

Whitehouse 2021
September 12, 2022
Whitehouse 2021

Pres. Biden Issues Executive Order on Advancing Biotechnology and Biomanufacturing

By MedTech Intelligence Staff
No Comments

The order outlines a “whole-of-government approach” to advance biotechnology and biomanufacturing towards innovative solutions in health, climate change, energy, food security, agriculture, supply chain resilience and national and economic security.

Continue reading →

Post navigation

  • 1
  • 2
  • 3
  • …
  • 81
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.

FST's COVID-19 Resource Center



Topic Archives

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Column Archives

  • Ameing for Asia
  • Ask the Engineer
  • CAPA Corner
  • Devine Guidance
  • From The Editor’s Desk
  • MEDdesign
  • Reimbursement Report
  • Soapbox

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2023 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.